| Financial Year |
March 31 2023 |
| Monetary Funds |
583,385,990.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
35,905,948.36 |
| Accounts Receivable |
868,497,541.15 |
| Advances to Suppliers |
26,010,679.10 |
| Other Receivables |
22,372,934.03 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
539,024,317.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,026,819.35 |
| Total Current Assets |
2,113,869,398.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
170,692,487.09 |
| Investment Properties |
47,271,124.99 |
| Fixed Assetes |
150,099,775.50 |
| Under-construction Projects |
2,313,162.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,946,315.57 |
| R&D expenses |
701,875.57 |
| Goodwill |
128,367,698.52 |
| Long-Term Deferred and Prepaid Expenses |
11,305,940.81 |
| Deferred Income Tax Assets |
21,333,236.05 |
| Other Non-Current Assets |
1,041,489.00 |
| Sub-Total of Non-Current Assets |
693,360,824.79 |
| Total Assets |
2,807,230,222.79 |
| Short-Term Loans |
134,536,426.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
127,086,648.30 |
| Accounts Payable |
280,238,183.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,279,871.34 |
| Taxes Payable |
15,671,731.36 |
| Interest Payable |
38,361.12 |
| Dividend Payable |
-- |
| Other payables |
3,037,547.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
36,232,170.02 |
| Other Current Liabilities |
3,197,606.46 |
| Sub-Total of Current Liabilities |
625,258,696.58 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
26,413,750.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,465,569.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
102,423,391.31 |
| Total Liabilities |
727,682,087.89 |
| Paid-In Capital(Or Share Stock) |
172,146,312.00 |
| Capital Surplus |
890,018,127.50 |
| Surplus Reserve |
52,347,986.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
774,565,986.45 |
| Minority Stockholder's Interest |
144,909,722.18 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,934,638,412.72 |
| Owner's Equity（Stockholder's Equity） |
2,079,548,134.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,807,230,222.79 |
